KeyBank National Association’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.75M Sell
10,678
-1,523
-12% -$678K 0.02% 303
2025
Q1
$5.92M Buy
12,201
+83
+0.7% +$40.2K 0.02% 272
2024
Q4
$4.88M Buy
12,118
+147
+1% +$59.2K 0.02% 293
2024
Q3
$5.57M Sell
11,971
-1,694
-12% -$788K 0.02% 277
2024
Q2
$6.41M Buy
13,665
+652
+5% +$306K 0.03% 256
2024
Q1
$5.44M Sell
13,013
-781
-6% -$326K 0.02% 276
2023
Q4
$5.61M Sell
13,794
-814
-6% -$331K 0.02% 266
2023
Q3
$5.08M Sell
14,608
-25
-0.2% -$8.69K 0.02% 262
2023
Q2
$5.15M Sell
14,633
-95
-0.6% -$33.4K 0.02% 267
2023
Q1
$4.64M Sell
14,728
-793
-5% -$250K 0.02% 272
2022
Q4
$4.48M Sell
15,521
-691
-4% -$200K 0.02% 276
2022
Q3
$4.69M Sell
16,212
-1,237
-7% -$358K 0.02% 256
2022
Q2
$4.92M Sell
17,449
-970
-5% -$273K 0.02% 264
2022
Q1
$4.81M Sell
18,419
-1,350
-7% -$352K 0.02% 276
2021
Q4
$4.34M Sell
19,769
-7,086
-26% -$1.56M 0.02% 292
2021
Q3
$4.87M Sell
26,855
-6,306
-19% -$1.14M 0.02% 268
2021
Q2
$6.69M Sell
33,161
-13,751
-29% -$2.77M 0.03% 241
2021
Q1
$10.1M Sell
46,912
-42,535
-48% -$9.14M 0.05% 210
2020
Q4
$21.1M Sell
89,447
-38,958
-30% -$9.21M 0.1% 149
2020
Q3
$34.9M Sell
128,405
-1,017
-0.8% -$277K 0.19% 109
2020
Q2
$37.6M Buy
129,422
+42,505
+49% +$12.3M 0.22% 102
2020
Q1
$20.7M Buy
86,917
+27,636
+47% +$6.58M 0.14% 127
2019
Q4
$13M Buy
59,281
+57,190
+2,735% +$12.5M 0.07% 180
2019
Q3
$354K Sell
2,091
-230
-10% -$38.9K ﹤0.01% 792
2019
Q2
$426K Sell
2,321
-19
-0.8% -$3.49K ﹤0.01% 783
2019
Q1
$430K Sell
2,340
-6
-0.3% -$1.1K ﹤0.01% 745
2018
Q4
$389K Buy
2,346
+52
+2% +$8.62K ﹤0.01% 716
2018
Q3
$442K Sell
2,294
-429
-16% -$82.7K ﹤0.01% 798
2018
Q2
$463K Buy
2,723
+426
+19% +$72.4K ﹤0.01% 765
2018
Q1
$374K Buy
2,297
+223
+11% +$36.3K ﹤0.01% 827
2017
Q4
$311K Sell
2,074
-2,440
-54% -$366K ﹤0.01% 884
2017
Q3
$686K Sell
4,514
-73
-2% -$11.1K ﹤0.01% 689
2017
Q2
$591K Buy
4,587
+232
+5% +$29.9K ﹤0.01% 758
2017
Q1
$476K Sell
4,355
-210
-5% -$23K ﹤0.01% 829
2016
Q4
$336K Buy
4,565
+1,382
+43% +$102K ﹤0.01% 935
2016
Q3
$277K Buy
3,183
+167
+6% +$14.5K ﹤0.01% 1006
2016
Q2
$259K Sell
3,016
-143
-5% -$12.3K ﹤0.01% 980
2016
Q1
$251K Sell
3,159
-1,118
-26% -$88.8K ﹤0.01% 974
2015
Q4
$538K Sell
4,277
-1,903
-31% -$239K ﹤0.01% 753
2015
Q3
$644K Buy
6,180
+901
+17% +$93.9K ﹤0.01% 705
2015
Q2
$652K Sell
5,279
-3,504
-40% -$433K ﹤0.01% 736
2015
Q1
$1.04M Buy
8,783
+5,503
+168% +$649K 0.01% 624
2014
Q4
$390K Sell
3,280
-61
-2% -$7.25K ﹤0.01% 941
2014
Q3
$375K Sell
3,341
-683
-17% -$76.7K ﹤0.01% 960
2014
Q2
$381K Sell
4,024
-989
-20% -$93.6K ﹤0.01% 1002
2014
Q1
$355K Sell
5,013
-162
-3% -$11.5K ﹤0.01% 1030
2013
Q4
$385K Sell
5,175
-4,509
-47% -$335K ﹤0.01% 997
2013
Q3
$734K Buy
9,684
+625
+7% +$47.4K 0.01% 748
2013
Q2
$724K Buy
+9,059
New +$724K ﹤0.01% 866